In vitro synthesis of the iron-molybdenum cofactor (FeMo-co) of dinitrogenase using homocitrate and its analog allows the formation of modified forms of FeMo-co that show altered substrate specificities (N2, acetylene, cyanide, or proton reduction) ofnitrogenase [reduced ferredoxin:dinitrogen oxidoreductase (ATP-hydrolyzing), EC 1.18.6.1]. The (LR,2S)-threo-and (1S,2S)-erythro-fluorinated diastereomers of homocitrate have been incorporated in vitro into dinitrogenase in place of homocitrate. Dinitrogenase activated with FeMo-co synthesized using threo-fluorohomocitrate reduces protons, cyanide, and acetylene but cannot reduce N2. In addition, proton reduction is inhibited by carbon monoxide (CO), a characteristic of dinitrogenase from NifV-mutants. Dinitrogenase activated with FeMo-co synthesized using erythro-fluorohomocitrate reduces protons, cyanide, acetylene, and N2. In this case proton reduction is not inhibited by CO, a characteristic of the wild-type enzyme. Cyanide reduction properties ofdinitrogenase activated with FeMo-co containing either fluorohomocitrate diastereomer are similar, and CO strongly inhibits cyanide reduction. Dinitrogenases activated with FeMo-co containing homocitrate analogs with a hydroxyl group on the C-1 position are much less susceptible to CO inhibition of cyanide reduction. However, proton and cyanide reduction by dinitrogenase containing FeMo-co activated with (1R,2S) threo-isocitrate is only one-third that of dinitrogenase activated with the racemic mixture of isocitrate and shows strong CO inhibition ofsubstrate reduction. These results suggest that CO inhibition of proton and cyanide reduction occurs when the hydroxyl group on the C-1 position of analogs is "trans" to the C-2 carboxyl group (i.e., in the threo conformation). When racemic mixtures ofthese analogs are used in the system, it seems that the erythro form is preferentially incorporated into dinitrogenase. Finally, carbonyl sulfide inhibition of substrate reduction by dinitrogenase is dependent on the homocitrate analog incorporated into FeMo-co.
Biological systems utilize nitrogenase [reduced ferredoxin: dinitrogen oxidoreductase (ATP-hydrolyzing), EC 1.18.6.1] to catalyze the ATP-and reductant-dependent reduction of N2 to ammonium. Nitrogenase consists of two proteins: dinitrogenase (MoFe protein or component I) and dinitrogenase reductase (Fe protein or component II) (1, 2) . Dinitrogenase reductase transfers electrons one at a time to dinitrogenase with concomitant hydrolysis of ATP. Electrons passed to dinitrogenase are channeled to a prosthetic group called the iron-molybdenum cofactor (FeMo-co), which is the ultimate site of substrate reduction.
Analysis of mutants of Klebsiella pneumoniae defective in nitrogen fixation (nif) has shown that at least six gene products (nifQ, nifB, nifN, nifE, nifH, and nifV) are involved in the synthesis of active FeMo-co. The nifQ gene product is apparently required for early steps in the processing of Mo for FeMo-co (3) . Strains with mutations in nifB, nifN, and nifE produce an apodinitrogenase that can be activated in vitro by purified FeMo-co (4) . Strains of K. pneumoniae and Azotobacter vinelandii with mutations in nifH (the structural gene for dinitrogenase reductase) also fail to synthesize FeMo-co (5, 6 ). An in vitro system for the synthesis of FeMo-co has been described that requires molybdate, at least the nifB, nifN, and nifE gene products (7) , dinitrogenase reductase (6, 8, 9) , and (R)-2-hydroxy-1,2,4-butanetricarboxylic acid (homocitric acid) (10) .
The in vitro FeMo-co synthesis system (7) allows the incorporation of homocitrate and its analogs (i.e., citrate, isocitrate, homoisocitrate, and such) to produce modified forms of FeMo-co. In the absence of homocitrate or one of its analogs, no FeMo-co is formed in vitro as determined by acetylene and proton reduction assays and by lack of 99Mo incorporation into apodinitrogenase (11) . Homocitrate has been shown to be an integral part of the FeMo-co of dinitrogenase, with one mole of homocitrate found for each mole of Mo (12) .
Several organic acids ( Fig. 1 ) were tested for their ability to replace homocitrate in the FeMo-co synthesis system (11, 13) . The resulting variant forms of FeMo-co exhibited altered substrate specificity and inhibitor susceptibility. Use of citrate in place of homocitrate in the in vitro FeMo-co synthesis system resulted in the formation of holodinitrogenase with effective proton and acetylene reduction activities but with poor N2 reduction and no 1H2H formation. In addition, proton reduction is inhibited by carbon monoxide (CO). These results are analogous to dinitrogenase from nifV mutants (14, 15) , and recently citrate was found in the dinitrogenase of such mutants (16) . Dinitrogenase activated with FeMo-co containing homoisocitrate, isocitrate, or 1-OH citrate effectively catalyzed the reduction of protons but not the reduction of acetylene or N2 (13) . The highest stringency pertaining to substrate specificity was found for N2 reduction, a six-electron process. 15N enrichment observed in experiments where apodinitrogenase was activated with homocitrate/FeMo-co was 80 times that of background levels, compared with citrate/FeMo-co with 6.3 times background levels (13) . These data suggest that none of the FeMo-co analogs tested produce a dinitrogenase capable of supporting significant diazotrophic growth.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. MATERIALS AND METHODS Nitrogenase Assays. Assays were performed in the presence of excess dinitrogenase reductase. Acetylene and proton reduction assays (7) with or without CO (11) have been described. Cyanide reduction assays were analogous to those described by Hoover et al. (11) with the addition of 80 ,ul of 0.2 M KCN in 0.4 M Mops, pH 7.5. Cyanide solutions were prepared anaerobically at pH 7.5 and contained 1.7 mM dithionite. N2 reduction was assayed by the "IN2 fixation method (17) using 99% '5N2 added after preincubation. Bacterial strains, preparation of crude extracts, and sources of homocitrate analogs are described in refs. 11 and 13. (18) with minor modifications. This method utilizes di-t-butyl-2-oxoglutarate and the enolate of t-butyl fluoroacetate to form tri-t-butyl-1-fluorohomocitrate. 1 1 The diastereomers were separated using a silica gel column (4 x 20 cm) under pressure (0.3 bar; 1 bar = 10 kPa) and eluted with hexane/ether, 5:1 (vol/vol). Tri-t-butyl-1-fluorohomocitrate (1 g ) was loaded onto the column and thirty 25-ml fractions were collected. The threo form of the fluorinated triester eluted first and separation of the two diastereomers was confirmed by 1H NMR. The diastereomers were placed in separate 10-ml round-bottom flasks and 3 ml of 10 M HCI was added to each flask. The contents were refluxed at 90'C in an oil bath for 5 hr and left overnight at room temperature. Water (10 ml) was added to each round-bottom flask, the contents were transferred to separatory funnels, and 10 ml of dichloromethane was added to each to remove unreacted material. The water was then removed under reduced pressure. The crystals of threo diastereomer (120 mg) were dissolved in 0.5 ml of H2O, and the solution was brought to pH 10 with 12 M NaOH, diluted with 4.5 ml of water, and stored at -20°C. The (9, 12) , along with 0.2 ml of an ATP-regenerating mixture which contained 5 mM sodium dithionite and 0.05 mM sodium molybdate (7) and the indicated concentrations of organic acids. The reaction mixtures were incubated at 30°C for 35 min, after which 0.8 ml of additional ATP-regenerating mixture containing 5 mM sodium dithionite was added, together with purified dinitrogenase reductase (7) and assayed. ND, not determined. Addition of excess purified FeMo-co to the UW45 extracts used resulted in an activity of 44.9 nmol of ethylene formed per min per assay. Numbers in parentheses are percent inhibition by CO or COS. One hundred microliters of CO (COS) gas was injected in an assay vial containing an 8-ml gas phase. Solutions of organic acids were prepared in dilute NaOH to a final pH of 9 prior to assay. (Table 1) . These results suggest that CO inhibition of proton reduction may be associated with electronic alterations around the hydroxyl or carboxyl groups attached to the C-2 position of the homocitrate analog (Fig.  1) . The fluorine atom of threo-fluorohomocitrate is cis with respect to the C-2 hydroxyl group and trans with respect to the C-2 carboxyl group, while the fluorine of erythrofluorohomocitrate is trans with respect to the C-2 hydroxyl group and cis with respect to the C-2 carboxyl group. The fluorine atom (with its three electron pairs) may be perturbing the metal ligating properties of the C-2 hydroxyl or carboxyl oxygen atoms. Imperial et al. (13) Dinitrogenase containing homoisocitrate, isocitrate, or 1-OH citrate effectively reduced protons without CO inhibition. However, dinitrogenase containing threo-isocitrate shows CO inhibition of proton reduction similar to that of dinitrogenase containing threo-fluorohomocitrate or citrate. Isocitrate does not contain a C-2 hydroxyl group, yet the threo diastereomer of isocitrate contains a hydroxyl group trans to the C-2 carboxyl group and shows CO inhibition. This suggests that dinitrogenase containing homocitrate analogs with atoms having electron pairs attached to the C-1 position will show CO inhibition of proton and cyanide reduction if these atoms are trans to the C-2 carboxyl group (i.e., cis to the C-2 hydroxyl group or in the threo conformation).
The relationship between CO inhibition and the atoms attached to the C-1 carbon relative to the C-2 chiral center in homocitrate analogs was further investigated by analyzing CO inhibition of cyanide reduction with analog-activated dinitrogenases. CO effectively inhibited cyanide reduction by dinitrogenase containing homocitrate (89%), erythro-fluorohomocitrate (99%), threo-fluorohomocitrate (100%), threoisocitrate (87%Y), or citrate (85%). Very little CO inhibition was observed for dinitrogenases activated with FeMo-co synthesized using racemic mixtures of homoisocitrate (24%), isocitrate (9%), or 1-OH citrate (16%). These results show that the presence of a hydroxyl group cis to the C-2 carboxyl group of homocitrate analogs prevents CO inhibition.
Preferential Incorporation of erythro Diastereomers. The proton and cyanide reduction activities of dinitrogenase containing the threo diastereomer of isocitrate were 33% and 37% that of the dinitrogenase activated by FeMo-co synthesized using a racemic mixture of isocitrate. In addition, dinitrogenase containing threo-isocitrate is susceptible to CO inhibition of proton and cyanide reduction. However, use of the racemic mixture of isocitrate for FeMo-co synthesis yields a dinitrogenase that effectively reduces protons and cyanide without CO inhibition. This suggests that the erythro diastereomer may be preferred for incorporation into FeMoco. In addition, CO inhibition of proton reduction by dinitrogenase activated by FeMo-co synthesized using a racemic mixture of fluorohomocitrate was characteristic of the erythro-fluorohomocitrate-containing enzyme (Table 1) . If the FeMo-co synthesis system were unable to discriminate between the two fluorinated diastereomers, then CO inhibition of proton reduction by the dinitrogenase activated by FeMo-co prepared using the racemic mixture should be about 30%o. Since identical CO inhibition was observed with dinitrogenase activated by FeMo-co prepared using either erythro-fluorohomocitrate or the racemic mixture of fluorohomocitrate, it seems that erythro-fluorohomocitrate is preferentially incorporated into dinitrogenase.
Effects of CO and Cyanide on Proton Reduction by Altered Forms of Dinitrogenase. Proton reduction by dinitrogenases containing homocitrate analogs also was studied in the presence of cyanide (Table 2 ). In the absence ofany other suitable substrate (i.e., N2, acetylene, or cyanide) nitrogenase will reduce protons to H2. When cyanide was added to solutions of analog-activated dinitrogenases, little or no proton reduction was observed. However, when CO was added together with cyanide, the reduction of cyanide was inhibited, and increased proton reduction activity was observed (except for the dinitrogenase containing threo-fluorohomocitrate, which had shown CO inhibition of proton reduction without cyanide). Dinitrogenase activated by FeMo-co synthesized using racemic mixtures of homocitrate analogs that have a hydroxyl group on the C-1 position shows little or no CO inhibition of cyanide reduction. Therefore, little or no proton reduction was observed when CO was added in the presence of cyanide.
CO completely inhibits acetylene reduction by dinitrogenases containing homocitrate, fluorohomocitrate, citrate, or threo-isocitrate. However, CO does not completely inhibit acetylene reduction by dinitrogenases activated by FeMo-co synthesized using racemic mixtures of homocitrate analogs with a hydroxyl group on the C-1 position; (i.e., homoisocitrate, isocitrate, and 1-OH citrate exhibit 93%, 86%, and 84% inhibition, respectively).
The degree of CO inhibition of analog-activated dinitrogenase was dependent on the nature of substrate being reduced (protons < cyanide < acetylene). Lowe et al. (20) have proposed that substrate reduction is dependent on the oxi-dation state of FeMo-co. Since CO inhibition was dependent on the substrate being reduced by dinitrogenase, it would seem that the more reduced forms are more susceptible to CO inhibition.
Carbonyl Sulfide (COS) Inhibition of Substrate Reduction by Altered Forms of Dinitrogenase. Because COS is an analog of CO, and CO inhibits the reduction of all substrates except protons by dinitrogenase (21), COS was tested as a possible inhibitor to obtain further information on analog-activated dinitrogenases.
COS inhibition of proton and acetylene reduction by dinitrogenase was found to be dependent on the homocitrate analog used during in vitro FeMo-co synthesis (Table 1) Dinitrogenase activated with FeMo-co synthesized using the racemic mixture of C-1 hydroxyl acid analogs showed little or no COS inhibition of proton or cyanide reduction. These results are analogous to CO inhibition patterns. Inhibition by COS was generally less than CO inhibition, and the degree of COS inhibition was generally dependent on which substrate was being reduced (protons < cyanide < acetylene). However, analog-activated dinitrogenases exhibiting CO inhibition of proton reduction showed markedly different COS inhibition patterns. Dinitrogenase containing threofluorohomocitrate, threo-isocitrate, or citrate had nearly equal CO and COS inhibition of proton reduction. With these analogs, the inhibition of proton reduction by COS was greater than that of cyanide reduction.
It is interesting that COS inhibits cyanide reduction by dinitrogenase containing either fluorinated diastereomer of homocitrate by 50%. Proton reduction by dinitrogenase containing erythro-fluorohomocitrate is not inhibited by CO, but COS inhibits this reduction 22%. In addition, the highest COS inhibition of cyanide and acetylene reduction occurred when dinitrogenase was activated with FeMo-co containing either fluorohomocitrate diastereomer. It seems that COS inhibition of substrate reduction is more pronounced with dinitrogenase activated with FeMo-co containing the fluorinated homocitrate analogs compared with other analogs.
CO and COS inhibit proton reduction by analog-activated dinitrogenase to similar extents. However, dinitrogenases containing homocitrate, citrate, or threo-isocitrate show high CO inhibition of cyanide reduction (89o, 85%, and 87%, respectively), while COS inhibition of cyanide reduction is low (4%, 18%, and 8%). These dramatic differences suggest that CO and COS may act upon different sites on the enzyme. SUMMARY These results further refine the model proposed by Imperial et al. (13) and establish that the stereochemistry at the C-1 position of homocitrate is crucial to the function of FeMo-co in dinitrogenase. Substrate reduction properties of altered forms of FeMo-co are dependent on atoms attached to the C-1 position relative to the carboxyl group attached to the C-2 position. Fluorine substitution for hydrogen atom at the C-1 position of fluorohomocitrate dramatically alters N2 reduction as well as CO (and COS) inhibition properties of dinitrogenase. Dinitrogenases activated with racemic mixtures of organic acids containing a hydroxyl group at the C-1 position show low CO and COS inhibition of proton and cyanide reduction. In addition, the erythro diastereomers of the homocitrate analogs (i.e., erythro-fluorohomocitrate or erythro-isocitrate) seem to be preferentially incorporated into FeMo-co over their threo counterparts.
CO (and COS) inhibition of substrate reduction is dependent on the homocitrate analog incorporated into FeMo-co. Lowe et al. (20) and Liang and Smith (22) have proposed that cyanide binds to a more oxidized form of FeMo-co than that required for proton or N2 reduction. Since CO inhibition was dependent on the substrate being reduced (protons < cyanide < acetylene), it would seem that the more-reduced forms of dinitrogenase are more susceptible to CO inhibition. Finally, differences in CO and COS inhibition suggest that COS may act at a different site (or by a different mechanism) than CO.
